Uloric Lawsuit Investigation: Risk of Heart Attack, Stroke

Last Updated on November 21, 2019

Important Information

Attorneys working with ClassAction.org are no longer investigating this matter. The information here is for reference only. A list of open investigations and lawsuits can be viewed here.

Comments |

Case Update

November 21, 2019

At A Glance

This Alert Affects:
Patients and loved ones of patients who took Uloric (febuxostat) and suffered a heart attack, stroke, heart-related death, or another critical cardiovascular event.
What Is Uloric?
Uloric (febuxostat) is a medication that was approved by the FDA in 2009 to treat gout by lowering uric acid levels in the blood.
What’s Going On?
Attorneys believe the maker of Uloric may have failed to warn patients of severe heart-related risks associated with using the drug. They are investigating whether lawsuits can be filed.
How Could a Lawsuit Help?
A lawsuit could help repay medical bills or other damages for people who experienced heart complications or stroke after taking Uloric.
Contact Us